ATLASNeuroSense Therapeutics (NRSN) earnings date: expected November 4–10
NeuroSense Therapeutics (NRSN) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around November 4–10. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NRSN
| Last price | $1.99 (-6.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.5% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 7 reports |
These figures come from the same calibrated model and valuation as the NeuroSense Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around November 4–10 (estimate). One email the day before, with ATLAS’s read on NeuroSense Therapeutics. You can switch it off at any time.
Alert me before NRSN reportsFree to start. Creating an account takes under a minute.
NRSN earnings at a glance
| Next report | Not announced · expected around November 4–10 (ATLAS estimate) |
|---|---|
| Last report | Jun 30, 2026 · Beat |
| Beat rate (last 7 reports) | 5 of 7 (71%) |
| Average EPS surprise | +41.4% |
| Average move around a report | ±6.8% (last 7) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between NeuroSense Therapeutics’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
NeuroSense Therapeutics earnings history: last 7 reports
NeuroSense Therapeutics last reported on Jun 30, 2026: EPS of $0.00 against an estimate of -$0.04 (+100.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.04 | $0.00 | +100.0% | Beat | +1.8% |
| Mar 25, 2026 | -$0.11 | $0.00 | +100.0% | Beat | +5.5% |
| Feb 3, 2026 | $3.32 | $3.33 | +0.3% | In line | -3.4% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -1.7% |
| Nov 19, 2025 | $3.21 | $3.63 | +13.1% | Beat | -13.7% |
| Apr 7, 2025 | -$3.00 | -$1.20 | +60.0% | Beat | -4.2% |
| Dec 18, 2024 | -$2.20 | -$2.20 | 0.0% | In line | +17.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NRSN
See the fair value, the probability range and the earnings history of NeuroSense Therapeutics on its ATLAS page.
NeuroSense Therapeutics (NRSN) stock analysisPlans from €3.99 a month.
NeuroSense Therapeutics earnings: frequently asked questions
When is NeuroSense Therapeutics (NRSN) next earnings date?
NeuroSense Therapeutics has not announced its next report. Its last 4 reports came Jun 30, 2026, Mar 25, 2026, Jan 23, 2026, Nov 19, 2025, so ATLAS estimates the next one around November 4–10. This is an estimate based on that pattern, not a confirmed date.
How often does NRSN beat earnings estimates?
Of its last 7 reports with a recorded result, NeuroSense Therapeutics beat the EPS estimate 5 times; the average surprise was +41.4%. Past results do not predict the next one.
How much does NRSN move around earnings?
Over its last 7 reports the stock moved an average of 6.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 7 times.
Did NeuroSense Therapeutics beat earnings estimates last quarter?
NeuroSense Therapeutics last reported on Jun 30, 2026: EPS of $0.00 against an estimate of -$0.04 (+100.0% surprise), a beat.
How much does NRSN usually move in a day?
On a normal trading day the ATLAS model puts NRSN’s one-day range at about ±10.5%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer